Home > National Drug Code (NDC) > Terazosin hydrochloride

Terazosin hydrochloride - 67544-562-92 - (Terazosin hydrochloride)

Alphabetical Index


Drug Information of Terazosin hydrochloride

Product NDC: 67544-562
Proprietary Name: Terazosin hydrochloride
Non Proprietary Name: Terazosin hydrochloride
Active Ingredient(s): 2    mg/1 & nbsp;   Terazosin hydrochloride
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of Terazosin hydrochloride

Product NDC: 67544-562
Labeler Name: Aphena Pharma Solutions - Tennessee, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA075317
Marketing Category: ANDA
Start Marketing Date: 20041220

Package Information of Terazosin hydrochloride

Package NDC: 67544-562-92
Package Description: 270 CAPSULE in 1 BOTTLE, PLASTIC (67544-562-92)

NDC Information of Terazosin hydrochloride

NDC Code 67544-562-92
Proprietary Name Terazosin hydrochloride
Package Description 270 CAPSULE in 1 BOTTLE, PLASTIC (67544-562-92)
Product NDC 67544-562
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Terazosin hydrochloride
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 20041220
Marketing Category Name ANDA
Labeler Name Aphena Pharma Solutions - Tennessee, Inc.
Substance Name TERAZOSIN HYDROCHLORIDE
Strength Number 2
Strength Unit mg/1
Pharmaceutical Classes Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]

Complete Information of Terazosin hydrochloride


General Information